- Research works
- 24 ▲ 161% vs 2013–17
- Citations
- 800 33.6 per fractional work
- Top-10% rate
- 24.0% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: AskBio (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.4×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 8.4×
- Neuroscience 6.7×
- Decision Sciences 5.2×
- Immunology and Microbiology 4.8×
- Pharmacology, Toxicology and Pharmaceutics 4.7×
- Health Professions 1.6×
- Arts and Humanities 1.2×
- Medicine 1.1×
- Agricultural and Biological Sciences 0.3×
- Social Sciences 0.2×
- Materials Science 0.1×
Which keywords describe research at AskBio (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, AAV, Viral Vectors, Open Access, Peer Review, Glycosylation, Genome Engineering and RNA-Guided.
- COVID-19
- RNA-Guided
- Genome Engineering
- Peer Review
- Epidemiology
- AAV
- Gene Therapy
- Viral Vectors
- Open Access
- Glycosylation
- Mammalian Cells
- Recombinant Protein
- Preprints
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 13 words, with their numbers
- Gene Therapy4▲ 57×3 topics
- AAV3▲ 189×1 topic
- Viral Vectors3▲ 189×1 topic
- Epidemiology2▲ 1.75×8 topics
- Open Access1▲ 68×2 topics
- Peer Review1▲ 178×2 topics
- Glycosylation1▲ 23×2 topics
- Genome Engineering1▲ 79×1 topic
- Mammalian Cells1▲ 113×1 topic
- RNA-Guided1▲ 79×1 topic
- Recombinant Protein1▲ 113×1 topic
- COVID-191▲ 6.4×1 topic
- Preprints1▲ 367×1 topic
Which research topics does AskBio (United States) publish most on?
By volume in 2022–2025: Virus-based gene therapy research, CRISPR and Genetic Engineering, Nerve injury and regeneration and Genetic Neurodegenerative Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Virus-based gene therapy research Genetics 1 works
- 2 CRISPR and Genetic Engineering Molecular Biology 1 works
- 3 Nerve injury and regeneration Cellular and Molecular Neuroscience 0 works
- 4 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
- 5 RNA Interference and Gene Delivery Molecular Biology 0 works
- 6 Cell death mechanisms and regulation Molecular Biology 0 works
- 7 DNA and Nucleic Acid Chemistry Molecular Biology 0 works
- 8 Academic Publishing and Open Access Information Systems and Management 0 works
- 9 Publishing and Scholarly Communication History and Philosophy of Science 0 works
- 10 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AskBio (United States)'s research output changed?
Output in 2018–2022 was 161% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chapel Hill
- University of North Carolina at Chapel Hill
- University of North Carolina Health Care
- University of North Carolina Hospitals
- Communities In Schools of Orange County
- Rho (United States)
- Chapel Hill Carrboro City Schools
- Renaissance Computing Institute
- Horizon Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.